Spero Therapeutics, Inc. (SPRO): 8-K filed Aug 12, 2026

Form type
8-K
Filing date
Aug 12, 2026
Accession number
0001193125-26-346855
Filer
Spero Therapeutics, Inc. (CIK 1701108)